Loading stock data…
MD
$22.75+0.24 (+1.07%)
Market ClosedLast close May 1
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Pediatrix Medical Group, Inc. in the Healthcare sector is trading at $22.75. The stock is currently near its 52-week high of $24.99, remaining 17.2% above its 200-day moving average. Technical signals show neutral RSI of 60 and bearish MACD signal, explaining why MD maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Neutral momentum (RSI 60) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$22.75
Potential Upside
72.7%
Whystock Fair Value$39.28
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus6 analysts
Buy
Mean target$22.17-2.6%
Range$19.00 – $27.00
Fundamentals
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications wi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.92B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
11.89
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.69%
Volume
Today's trading volume
606,464
Recent News
Organon (OGN) Q1 Earnings and Revenues Miss Estimates
Organon (OGN) delivered earnings and revenue surprises of -14.87% and -0.48%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
3 Value Stocks with Open Questions
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Reasons MD is Risky and 1 Stock to Buy Instead
Pediatrix Medical Group has had an impressive run over the past six months as its shares have beaten the S&P 500 by 31.6%. The stock now trades at $23.07, marking a 36.2% gain. This performance may have investors wondering how to approach the situation.
Truist Lifts PT on Pediatrix Medical Group (MD) to $23 From $21 – Here’s Why
Pediatrix Medical Group, Inc. (NYSE:MD) is one of the most undervalued small cap stocks to buy right now. On April 13, Truist lifted the price target on Pediatrix Medical Group, Inc. (NYSE:MD) to $23 from $21, reiterating a Hold rating on the shares. The rating update came as part of a broader research note previewing fiscal […]